SUPRASORB X+PHMB 20542

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,foreign report with the FDA on 2015-06-15 for SUPRASORB X+PHMB 20542 manufactured by Lohmann & Rauscher International Gmbh & Co..

Event Text Entries

[6263824] Systemic reaction of uncleared causality with suspicion of an anaphylactic reaction to the dressing suprasorb x +phmb - placed on a patient with large chronic and critically infected wound in the scalp/neck region - was described by a healthcare professional in new zealand. The pt concerned developed a tingling sensation after application of the dressing, with flushed red skin and an extensive raised papular rash on the upper body. He became tachycardic and hypotensive. After removing the dressing and comprehensive treatment, the pt was stable and made full recovery from the reaction. Please notice: a systemic antibiosis was given for a couple of days before the anaphylactoid reaction occurred and on the same day, the skin of the upper arm was disinfection with chlorhexidine and 0. 1% polyhexanide containing pronotosan cleansing solution. The event was evaluated by the manufacturer as a labeled-case and therefore a non-reportable expected and foreseeable adverse event, voluntarily reported to the authorities in (b)(4) via distributor.
Patient Sequence No: 1, Text Type: D, B5


[14245830] Uncleared clinical causality. The side-effect was considered in the clinical evaluation and therefore evaluated as expected and foreseeable adverse event. The ifu already includes: "side-effects" in very rare cases skin irritations or allergies may occur. " risk analysis considered "allergic reactions" as known risk. Since suprasorb x+phmb was put into market by l&r in 2006 two cases with anaphylactoid reactions were reported. L&r is reported based on the draft guidelines "draft guidance for industry and fda staff - medical device reproting for manufacturers" issued on: (b)(4) 2013, section 4. 11. 3 l&r is marketing the following device that is of identical build in the unites states market: distributor ref: xyl040o210, mr. Ref (b)(4), xcell cellulose wound dressing antimicrobial, 5. 5" x 8", 510(k) #: c, mfr. :lohmann and rauscher (b)(4), johann-schorsch-gasse 4, 1141 wien, austria, registration#: (b)(4). Packaging was lost in hospital therefore lot # of the used device is not available.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number9611462-2015-00001
MDR Report Key4888427
Report Source01,FOREIGN
Date Received2015-06-15
Date of Report2015-06-11
Date of Event2015-05-04
Date Mfgr Received2015-04-05
Date Added to Maude2015-07-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer StreetWESTERWALDSTR. 4
Manufacturer CityRENGSDORF 56579
Manufacturer CountryGM
Manufacturer Postal56579
Manufacturer Phone2631996907
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSUPRASORB X+PHMB
Generic NameANTIMICROBIAL HYDROBALANCE WOUND DRE
Product CodeMGQ
Date Received2015-06-15
Model Number20542
Lot NumberUNK
ID NumberREF# 20542
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerLOHMANN & RAUSCHER INTERNATIONAL GMBH & CO.
Manufacturer AddressNEUWIED, RHEINLAND-PFALZ GM


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2015-06-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.